Stocktoria
Acrivon Therapeutics, Inc. ACRV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-11-15
Acrivon Therapeutics, Inc. statistics & valuation
Market cap$71.9M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -60.1% | -41.0% | -43.7% | -17.2% | -15.2% |
| Return on equity | -69.2% | -45.6% | -49.8% | -18.3% | 68.2% |
| Current ratio | 7.69 | 10.55 | 9.75 | 20.27 | 34.46 |
Source: SEC EDGAR filings · CIK 0001781174 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.